5-Amino-1MQ is studied in laboratory enzyme assays involving NNMT inhibition, methyl metabolism, and NAD+-associated metabolic pathways.
- NNMT enzyme assays
- Methyl metabolism
- NAD+-associated pathways
NNMT is the assay name in 5-Amino-1MQ papers
Those enzyme assays are not MOTS-C AMPK papers and not NAD+ sirtuin papers, even when NAD is in the discussion.
The certificate is the November 9, 2025 report, task 7542.
No purity row
The documented figure is 53.85 mg of 5-Amino-1-methylquinolinium.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
5-Amino-1MQ 50 mg research questions
What is filed here?
NNMT enzyme assays, methyl metabolism, and NAD+-associated pathways.
What is the printed mass?
53.85 mg.
References and further reading
- PubMed literature index — 5-Amino-1MQ 50 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.